The synthetic peptide was pre-incubated with DPP-IV to determine stability against DPP-IV. Based on this peptide stability, inhibitors of DPP-IV were classified into substrate, prodrug, or true inhibitor type. According to the previous method by Nongonierma et al. [37] with slight modification, 50 μL of peptides (500 µM) dissolved in 1% DMSO were pre-incubated with 100 μL of DPP-IV (1 U/μL) in DPP-IV buffer at 37 °C for 3 h. Consequently, 75 µL of pre-incubation mixture was combined with 25 µL of 2 mM NaOH and 25 µL of 1.6 mM Gly-Pro-p-nitroanilide, and further pre-incubated at 37 °C for 10 min. The mixture was added with 25 µL of DPP-IV buffer and then incubated at 37 °C for 60 min. The reaction was ended using 100 µL of 1M sodium acetate at pH 4.0. The absorbance of each reaction was measured at 405 nm in a SpectraMax 190 Microplate Reader (Molecular Devices, LLC, San Jose, CA, USA) to determine DPP-IV inhibitory activity of peptide after a pre-incubation period. The remaining 75 µL of the original mixture was heat-inactivated at 95 °C for 10 min to end enzyme activity after which it was injected into LC-MS to confirm the stability of the peptide.
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.